182705 Sigma-AldrichAhR Antagonist - CAS 301326-22-7 - Calbiochem
The AhR Antagonist, also referenced under CAS 301326-22-7, controls the biological activity of AhR.
More>> The AhR Antagonist, also referenced under CAS 301326-22-7, controls the biological activity of AhR. Less<<Synonyms: 2-Methyl-2H-pyrazole-3-carboxylic acid-(2-methyl-4-o-tolyl-azophenyl)-amide, CH-223191
Recommended Products
개요
| Replacement Information |
|---|
주요 사양표
| CAS # | Empirical Formula |
|---|---|
| 301326-22-7 | C₁₉H₁₉N₅O |
가격 및 재고여부
| 카탈로그 번호 | 재고 정보 | 패킹 | 포장 단위 | 가격(VAT 별도) | 수량 | |
|---|---|---|---|---|---|---|
| 182705-10MGCN |
|
Plastic ampoule | 10 mg |
|
— |
| References | |
|---|---|
| References | Kim, S.H., et al. 2006. Mol. Pharmacol. 69, 1871. |
| Product Information | |
|---|---|
| CAS number | 301326-22-7 |
| ATP Competitive | N |
| Form | Orange-brown |
| Hill Formula | C₁₉H₁₉N₅O |
| Chemical formula | C₁₉H₁₉N₅O |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | AhR (aryl hydrocarbon receptor) |
| Primary Target IC<sub>50</sub> | 30 nM in blocking TCDD-induced AhR transcription activity in HepG2 cells in vitro |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 카탈로그 번호 | GTIN |
| 182705-10MGCN | 04055977204452 |
Documentation
AhR Antagonist - CAS 301326-22-7 - Calbiochem MSDS
| 타이틀 |
|---|
AhR Antagonist - CAS 301326-22-7 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 182705 |
References
| 참고문헌 보기 |
|---|
| Kim, S.H., et al. 2006. Mol. Pharmacol. 69, 1871. |



